Open AccessDecaprenyl Diphosphate Synthase Subunit 1 (PDSS1): A Potential Prognostic Biomarker and Immunotherapy-Target for Hepatocellular Carcinoma
Author(s) -
Yuping Yang,
Jinying Li,
Ming Tang,
Baisheng Nie,
Wei Huang
Publication year - 2022
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s364346
Subject(s) - hepatocellular carcinoma , immunotherapy , immune system , cancer research , cd8 , biology , cancer immunotherapy , biomarker , medicine , oncology , immunology , biochemistry
PDSS1 (decaprenyl diphosphate synthase subunit 1) plays an important role in the progression of several types of tumor. However, the biological functions of PDSS1 remain unclear in patients with hepatocellular carcinoma (HCC). In this study, We attempted to determine the role of PDSS1 in predicting the survival and efficacy of immunotherapy for HCC patients.